DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,616 filers reported holding DANAHER CORPORATION in Q3 2020. The put-call ratio across all filers is 1.03 and the average weighting 0.7%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $370,733 | -47.2% | 1,494 | -48.9% | 0.30% | +153.8% |
Q2 2023 | $702,057 | -2.7% | 2,925 | +2.2% | 0.12% | -13.3% |
Q1 2023 | $721,637 | -3.5% | 2,863 | +1.6% | 0.14% | -12.9% |
Q4 2022 | $747,990 | +79.8% | 2,818 | +74.9% | 0.16% | +86.7% |
Q3 2022 | $416,000 | -43.0% | 1,611 | -44.0% | 0.08% | -39.9% |
Q2 2022 | $730,000 | -14.1% | 2,878 | -0.7% | 0.14% | +1.5% |
Q1 2022 | $850,000 | -10.9% | 2,899 | 0.0% | 0.14% | -2.9% |
Q4 2021 | $954,000 | -1.0% | 2,899 | -8.4% | 0.14% | -6.0% |
Q3 2021 | $964,000 | -2.5% | 3,166 | -13.9% | 0.15% | -5.1% |
Q2 2021 | $989,000 | +99.4% | 3,677 | +66.9% | 0.16% | +72.5% |
Q1 2021 | $496,000 | -3.1% | 2,203 | -4.3% | 0.09% | -14.2% |
Q4 2020 | $512,000 | +21.0% | 2,303 | +17.3% | 0.11% | -63.8% |
Q3 2020 | $423,000 | +5.0% | 1,963 | -13.9% | 0.29% | +179.0% |
Q2 2020 | $403,000 | +11.3% | 2,279 | -12.7% | 0.10% | -7.1% |
Q1 2020 | $362,000 | +1911.1% | 2,611 | +1131.6% | 0.11% | +1312.5% |
Q2 2017 | $18,000 | – | 212 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |